EPS Creative Health Technology Group Limited (3860) Stock Statistics & Valuation Metrics

EPS Creative Health Technology Group Limited has a market cap or net worth of HK$326.16M. The enterprise value is HK$189.00M.

EPS Creative Health Technology Group Limited has 582,429,800 shares outstanding. The number of shares has decreased by -2.65% in one year.

EPS Creative Health Technology Group Limited’s return on equity (ROE) is -0.13 and return on invested capital (ROIC) is 0.39%.

The current PE Ratio of EPS Creative Health Technology Group Limited is ―. EPS Creative Health Technology Group Limited’s PEG ratio is 0.15.

In the last 12 months, EPS Creative Health Technology Group Limited had revenue of 457.65M and earned -13.85M in profits. Earnings per share was -0.03.

In the last 12 months, operating cash flow was 28.21M and capital expenditures -3.09M, giving a free cash flow of 25.11M billion.

EPS Creative Health Technology Group Limited pays an annual dividend of HK$0.01, resulting in a dividend yield of 1.79%

EPS Creative Health Technology Group Limited upcoming earnings date is Dec 2, 2026, TBA (Confirmed).

EPS Creative Health Technology Group Limited as a current ratio of 1.83, with Debt / Equity ratio of 4.20%

In the past 12 months, EPS Creative Health Technology Group Limited has paid 3.51M in taxes.

EPS Creative Health Technology Group Limited EV to EBITDA ratio is 9.14, with an EV/FCF ratio of 6.42.

EPS Creative Health Technology Group Limited has HK$130.49M in cash and marketable securities with HK$4.45M in debt, giving a net cash position of HK$126.04M billion.

Gross margin is 16.39%, with operating margin of 0.17%, and net profit margin of -3.03%.

The average price target for EPS Creative Health Technology Group Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―